Gastrointestinal Cancer
Conference Coverage
Adding SBRT to sorafenib boosts survival in liver cancer
The use of SBRT in this setting improved both overall survival and progression-free survival, researchers reported at ASCO GI.
Conference Coverage
Regorafenib: New option for advanced gastroesophageal cancer?
Regorafenib significantly improves survival, compared with placebo, in patients with refractory AGOC, researchers report at ASCO GI.
Feature
Canadian guidance recommends reducing alcohol consumption
Consuming no drinks per week has benefits.
Conference Coverage
Palliative radiotherapy successfully reduces end-stage liver cancer pain
Small study shows low-dose radiotherapy improves both pain and survival in hepatocellular carcinoma.
From the Journals
Does appendectomy raise the risk for colorectal cancer?
Researchers observed a 73% increase in CRC risk among appendectomy cases, compared with controls over a 20-year follow-up.
Feature
3D-printed tumor models could advance new cancer therapies
The impact could be “huge,” says Y. Shrike Zhang, PhD, of Harvard Medical School.
Latest News
People with cancer should be wary of taking dietary supplements
Many patients still think over-the-counter vitamins, minerals, or herbal remedies will help.
News
Tucatinib plus trastuzumab approved for HER2+ colorectal cancer
This is the first FDA-approved treatment for HER2-positive metastatic colorectal cancer.
From the Journals
Do biologics protect against cancer progression in IBD?
“These results indicate that biologics and 5-ASA are drugs that are potentially associated with a lower risk of advanced cancer in patients with...
Conference Coverage
Longest overall survival ever seen in advanced gastric cancer
“Zolbetuximab plus mFOLFOX6 is a new potential standard treatment for these patients.”
From the Journals
Interval FITs could cut colonoscopies in those at above-average risk
Two or more negative tests could suggest less need for colonoscopy at 5 years, especially in those with a family history of colon cancer.